Home / mesothelioma / mesothelioma law firm / Merck KGaA, Threshold win fast track for pancreatic cancer drug

Tuesday, May 12, 2015

Merck KGaA, Threshold win fast track for pancreatic cancer drug

By Unknown
On

Fox NewsMerck KGaA, Threshold win fast track for pancreatic cancer drugFox NewsFRANKFURT – Germany's Merck KGaA said that experimental cancer drug evofosfamide, which it is jointly developing with Threshold Pharmaceuticals, won fast track status for the treatment of advanced pancreatic cancer from the U.S. Food and Drug ...Threshold Pharmaceuticals' Partner Merck KGaA, Darmstadt, Germany ...CNNMoneyall 9 news articles »

Merck KGaA, Threshold win fast track for pancreatic cancer drug Rating: 4.5 Diposkan Oleh: Unknown

Subscribe to: Post Comments (Atom)
 

Top